You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

iHMA (injectable hypomethylating agents)

Showing 1 - 25 of 5,991
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Durvalumab)

Active, not recruiting
Has Results
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +65 more
Aug 19, 2022

Acute Myeloid Leukemia Trial in Worldwide (MBG453, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Birmingham, Alabama
  • +27 more
Jan 20, 2023

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Adelaide, Australia
  • +11 more
Oct 13, 2022

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Mar 1, 2023

Refractory Acute Myeloid Leukemia, Relapsed Acute Myelomonocytic Leukemia, MDS Trial in Cleveland (CPX-351)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Mar 15, 2022

Intervention Trial in Rochester (GO-EXCAP Mobile App)

Completed
  • Intervention
  • GO-EXCAP Mobile App
  • Rochester, New York
    University of Rochester Medical Center
Dec 7, 2021

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Nov 29, 2022

Schizophrenia Trial in Catonsville (Paliperidone)

Withdrawn
  • Schizophrenia
  • Catonsville, Maryland
    Maryland Psychiatric Research Center
Mar 1, 2022

Stroke, Acute Trial (OTR4132MD)

Recruiting
  • Stroke, Acute
  • OTR4132MD
  • Grenoble, Auvergne Rhône Alpes, France
  • +2 more
Oct 24, 2022

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)

Not yet recruiting
  • Hiv
  • Self-guided health education
  • +2 more
  • Bronx, New York
  • +5 more
Apr 17, 2023

Aesthetic Dermatology Trial in Plan-les-ouates (Dermal Filler Device)

Not yet recruiting
  • Aesthetic Dermatology
  • Dermal Filler Device
  • Plan-les-ouates, Switzerland
    Kylane Laboratoires
Nov 16, 2023

HIV, Opioid-Related Disorders, Pre-Exposure Prophylaxis (PrEP) Trial in Birmingham (SIRI Checklist, Enhanced Peer Recovery

Not yet recruiting
  • HIV Infections
  • +2 more
  • SIRI Checklist
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 27, 2022

Mid-face Volume Deficiency Trial in Stockholm (Adipearl)

Recruiting
  • Mid-face Volume Deficiency
  • Adipearl
  • Stockholm, Sweden
    Art Clinic
Sep 5, 2023

Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

Not yet recruiting
  • Acute Myeloid Leukemia
  • Tagraxofusp (Cycles 1-2)
  • +2 more
  • (no location specified)
Jun 28, 2022

Complications of DMPA Injectable Contraceptives Trial in Assiut (Depot-medroxy Progesterone Acetate Injectable Contraceptives)

Completed
  • Complications of DMPA Injectable Contraceptives
  • Depot-medroxy Progesterone Acetate Injectable Contraceptives
  • Assiut, Egypt
    Boshra Hussien Ahmed
Oct 20, 2023

Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

Recruiting
  • Human Immunodeficiency Virus
  • Opioid Use Disorder
  • Combined LAI Treatment: Cabenuva and Sublocade
  • Providence, Rhode Island
    Rhode Island Hospital
Aug 7, 2023

Compare the Effect of Injectable Platelets Rich Fibrin and Micro-osteoperforations on Root Resorption During Orthodontic

Enrolling by invitation
  • Compare the Effect of Injectable Platelets Rich Fibrin and Micro-osteoperforations on Root Resorption During Orthodontic Intrusion of Incisors
  • injectable platelet rich fibrin and microosteoperforation
  • Cairo, Egypt
    AlAzhar university
Jul 15, 2023

HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

Recruiting
  • HIV Infections
  • Oral Cabotegravir (CAB)
  • +4 more
  • La Jolla, California
  • +30 more
Feb 2, 2023

Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

Recruiting
  • Refractory Chronic Myelomonocytic Leukemia
  • Refractory Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2021